Profile
Mario Filion is the founder of Alethia Biotherapeutics, Inc. since 2002, holding the title of Chief Scientific Officer & Executive VP.
Former positions include Director-Molecular Genetics at Fortaleza Energy, Inc. and President-Clinical Genomics Division at SignalGene, Inc. Education includes a doctorate from the University of Montréal.
Mario Filion active positions
| Companies | Position | Start |
|---|---|---|
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets | Founder | 2001-12-31 |
Former positions of Mario Filion
| Companies | Position | End |
|---|---|---|
| FORTALEZA ENERGY INC. | Corporate Officer/Principal | - |
SignalGene, Inc. | Corporate Officer/Principal | - |
Training of Mario Filion
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Fortaleza Energy, Inc.
Fortaleza Energy, Inc. Integrated OilEnergy Minerals Engages in the exploration, development and production of crude oil and natural gas | Energy Minerals |
University of Montréal
University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets | Health Technology |
SignalGene, Inc. |
- Stock Market
- Insiders
- Mario Filion
















